These must be the two worst appointments imaginable for patients and access

March 20, 2024 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

It is hard to imagine two more troubling appointments than Health Minister Mark Butler's choices to lead the Pharmaceutical Benefits Advisory Committee and Medical Services Advisory Committee if you want access to new health technologies. …

Subscribe now to continue reading.

Latest Video

Pfizer clinches Metsera, reshaping the balance in global obesity therapy race
November 11, 2025 - Latest News
CSL welcomes MSAC support for gene therapy but questions 'strict cost-neutrality framework'
November 11, 2025 - Latest News
New Zealand accelerates medicines reform with major regulatory changes
November 12, 2025 - Latest News
Professor Robyn Ward - 'AI won’t replace us, but it will redefine how we work'
November 11, 2025 - Latest News
'AI Must Be trusted, transparent, and integrated in the future of health technology assessment'
November 11, 2025 - Latest News

These must be the two worst appointments imaginable for patients and access

This is a preview of subscriber content

Latest Video

Most Read

Pfizer clinches Metsera, reshaping the balance in global obesity therapy race

CSL welcomes MSAC support for gene therapy but questions 'strict cost-neutrality framework'

New Zealand accelerates medicines reform with major regulatory changes

Professor Robyn Ward - 'AI won’t replace us, but it will redefine how we work'

'AI Must Be trusted, transparent, and integrated in the future of health technology assessment'

New Stories

Arrotex launches new PBS-listed combination therapy as gap emerges in hypertension treatments

Sanofi building an AI-literate organisation through expectations, over experiments

Prospection says data access and leadership are critical to unlock AI’s potential in healthcare

The four 'H' words that can help drive the adoption of AI in health

Immutep posts encouraging Phase 2 results as 'Efti' spurs robust anti-tumour activity

PYC Therapeutics appoints Peter Coleman as new Chair as part of board renewal

New gene discoveries improve diagnosis of inherited heart disease

Sign In

These must be the two worst appointments imaginable for patients and access

This is a preview of subscriber content

Latest Video

Most Read

Pfizer clinches Metsera, reshaping the balance in global obesity therapy race

CSL welcomes MSAC support for gene therapy but questions 'strict cost-neutrality framework'

New Zealand accelerates medicines reform with major regulatory changes

Professor Robyn Ward - 'AI won’t replace us, but it will redefine how we work'

'AI Must Be trusted, transparent, and integrated in the future of health technology assessment'

Follow Us

New Stories

Arrotex launches new PBS-listed combination therapy as gap emerges in hypertension treatments

Sanofi building an AI-literate organisation through expectations, over experiments

Prospection says data access and leadership are critical to unlock AI’s potential in healthcare

The four 'H' words that can help drive the adoption of AI in health

Immutep posts encouraging Phase 2 results as 'Efti' spurs robust anti-tumour activity

PYC Therapeutics appoints Peter Coleman as new Chair as part of board renewal

New gene discoveries improve diagnosis of inherited heart disease